American Academy of Ophthalmology (AAO) 2023
Long-Term Efficacy and Safety of Pegcetacoplan Over 36 Months: Results From 12 Months of the GALE Open-Label Extension Study_Jeffrey Heier
Long-Term Efficacy and Safety of Pegcetacoplan Over 36 Months: Results From 12 Months of the GALE Open-Label Extension Study_Charles C. Wykoff, et al.
Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy: An Anchored Matching-Adjusted Indirect Comparison of Three Phase 3 Trials